{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:59:46Z","timestamp":1740149986321,"version":"3.37.3"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100007614","name":"Deanship of Scientific Research at Jouf University","doi-asserted-by":"publisher","award":["DSR-2021-01-03167"],"award-info":[{"award-number":["DSR-2021-01-03167"]}],"id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Type 1 diabetes mellitus (T1DM) is a chronic disease caused by destruction of insulin-producing pancreatic \u03b2-cells. During disease progression, inflammatory insulitis increases the presentation of islet antigens on human leukocyte antigen (HLA) molecules to T lymphocytes. This complex system plays a pivotal role in the cellular immunity. Thus, genetic variability in HLA can affect the susceptibility to and clinical outcomes of DM<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>This case-control study aimed to assess the role of HLA-DPrs3077 and HLA-DQrs3920 single-nucleotide polymorphisms (SNP) in T1DM.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Subjects and Methods:<\/jats:title>\n<jats:p>This study enrolled 400 individuals: 200 patients with T1DM and 200 ageand\nsex-matched healthy controls. Hemoglobin A1C and random, fasting, and postprandial blood\nsugar levels were determined for all subjects. Genotypic and allelic distributions of HLA-DPrs3077\n(A\/G) and HLA-DQrs3920 (A\/G) SNPs were determined using real-time polymerase chain reaction\n(PCR).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>Frequency of the HLA-DPrs3077A allele was high among the diabetic group (91.3%);\nhowever, the difference was non-significant [OR (95% C.I) = 1.422(0.89-2.252), P=0.098]. The\nfrequency of the HLA-DQrs3920 GG genotype was higher in control than the diabetic group (52.5%\nvs.12%), whereas that of the AA genotype was higher in the person with diabetes than in the control\ngroup (34% vs.4%). Individuals carrying the HLA-DQrs3920A allele were 4.5 times more likely to\nhave T1DM than those carrying the G allele [OR (95% C.I) = 4.510 (3.338- 6.094), P&lt;0.001*]. The\npresence of HLA-DPrs3077A and HLA-DQ rs3920A in the same person increases T1DM risk by\n3.6 times that of G allele [OR (95%C.I) = 3.608(2.173-5.991), P&lt;0.001*].<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>HLA-DPrs3077A and HLA-DQrs3920A may be alleles susceptible to T1DM, particularly if they coexist.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530323666221111153102","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T14:52:56Z","timestamp":1668178376000},"page":"850-856","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of HLA-DPrs3077 and HLA-DQrs3920 Polymorphisms as Risk\nFactors for Type 1 Diabetes Mellitus"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-1303","authenticated-orcid":true,"given":"Amany A.","family":"Ghazy","sequence":"additional","affiliation":[{"name":"Microbiology and Medical Immunology Unit, Department of Pathology, College of Medicine, Jouf University,\nSaudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3238\/arztebl.2018.0146","volume":"115","author":"Ziegler R.","year":"2018","unstructured":"Ziegler R.; Neu A.; Diabetes in childhood and adolescence. Dtsch Arztebl Int 2018,115(9),146-156","journal-title":"Dtsch Arztebl Int"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fgene.2018.00535","volume":"9","author":"Nyaga D.M.","year":"2018","unstructured":"Nyaga D.M.; Vickers M.H.; Jefferies C.; Perry J.K.; O\u2019Sullivan J.M.; Type 1 diabetes mellitus-associated genetic variants contribute to overlapping immune regulatory networks. Front Genet 2018,9,535","journal-title":"Front Genet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"Mobasseri M.","year":"2020","unstructured":"Mobasseri M.; Shirmohammadi M.; Amiri T.; Vahed N.; Hosseini Fard H.; Ghojazadeh M.; Prevalence and incidence of type 1 diabetes in the world: A systematic review and meta-analysis. Health Promot Perspect 2020,10(2),98-115","journal-title":"Health Promot Perspect"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fendo.2017.00343","volume":"8","author":"Burrack A.L.","year":"2017","unstructured":"Burrack A.L.; Martinov T.; Fife B.T.; T cell-mediated beta cell destruction: Autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol 2017,8,343","journal-title":"Front Endocrinol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.humimm.2021.07.010","volume":"82","author":"Nyg&#xE5;rd L.","year":"2021","unstructured":"Nyg&#xE5;rd L.; Laine A.P.; Kiviniemi M.; Toppari J.; H&#xE4;rk&#xF6;nen T.; Knip M.; Tri-SNP polymorphism in the intron of HLA-DRA1 affects type 1 diabetes susceptibility in the Finnish population. Hum Immunol 2021,82(12),912-916","journal-title":"Hum Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.6065\/apem.2019.24.3.143","volume":"24","author":"Lee H.S.","year":"2019","unstructured":"Lee H.S.; Hwang J.S.; Genetic aspects of type 1 diabetes. Ann Pediatr Endocrinol Metab 2019,24(3),143-148","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref=7","author":"Cruz-Tapias P.","year":"2013","unstructured":"Cruz-Tapias P.; Castiblanco J.; Anaya J.M.; Major histocompatibility complex: Antigen processing and presentation. Autoimmunity: From Bench to Bedside 2013","journal-title":"Autoimmunity: From Bench to Bedside"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"Pugliese A.","year":"2017","unstructured":"Pugliese A.; Autoreactive T cells in type 1 diabetes. J Clin Invest 2017,127(8),2881-2891","journal-title":"J Clin Invest"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/annrheumdis-2018-214725","volume":"78","author":"Guo J.","year":"2019","unstructured":"Guo J.; Zhang T.; Cao H.; Li X.; Liang H.; Liu M.; Zou Y.; Zhang Y.; Wang Y.; Sun X.; Hu F.; Du Y.; Mo X.; Liu X.; Yang Y.; Yang H.; Wu X.; Zhang X.; Jia H.; Jiang H.; Hou Y.; Liu X.; Su Y.; Zhang M.; Yang H.; Wang J.; Sun L.; Liu L.; Padyukov L.; Lai L.; Yamamoto K.; Zhang X.; Klareskog L.; Xu X.; Li Z.; Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population. Ann Rheum Dis 2019,78(6),773-780","journal-title":"Ann Rheum Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/ng.3395","volume":"47","author":"Moutsianas L.","year":"2015","unstructured":"Moutsianas L.; Jostins L.; Beecham A.H.; Dilthey A.T.; Xifara D.K.; Ban M.; Shah T.S.; Patsopoulos N.A.; Alfredsson L.; Anderson C.A.; Attfield K.E.; Baranzini S.E.; Barrett J.; Binder T.M.C.; Booth D.; Buck D.; Celius E.G.; Cotsapas C.; D\u2019Alfonso S.; Dendrou C.A.; Donnelly P.; Dubois B.; Fontaine B.; Fugger L.; Goris A.; Gourraud P.A.; Graetz C.; Hemmer B.; Hillert J.; Kockum I.; Leslie S.; Lill C.M.; Martinelli-Boneschi F.; Oksenberg J.R.; Olsson T.; Oturai A.; Saarela J.; S&#xF8;ndergaard H.B.; Spurkland A.; Taylor B.; Winkelmann J.; Zipp F.; Haines J.L.; Pericak-Vance M.A.; Spencer C.C.A.; Stewart G.; Hafler D.A.; Ivinson A.J.; Harbo H.F.; Hauser S.L.; De Jager P.L.; Compston A.; McCauley J.L.; Sawcer S.; McVean G.; Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet 2015,47(10),1107-1113","journal-title":"Nat Genet"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fimmu.2016.00202","volume":"7","author":"Ghazy A.A.","year":"2016","unstructured":"Ghazy A.A.; El-Etreby N.M.; Relevance of HLA-DP\/DQ and ICAM-1 SNPs among ovarian cancer patients. Front Immunol 2016,7,202","journal-title":"Front Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"100842","DOI":"10.1016\/j.mgene.2020.100842","volume":"27","author":"Mishra V.C.","year":"2021","unstructured":"Mishra V.C.; Deshpande T.; Gupta N.; Dorwal P.; Chandra D.; Raina V.; Sharma G.; Frequency analysis of HLA-B allele in leukemia patients from a North Indian population: A case-control study. Meta Gene 2021,27,100842","journal-title":"Meta Gene"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5539851","volume":"2021","author":"Alenzi M.J.","year":"2021","unstructured":"Alenzi M.J.; Ghazy A.A.; Taha D.E.; The weight of HLA-DPA1 rs3077 single nucleotide polymorphism in prostate cancer, a multicenter study. Prostate Cancer 2021,2021,1-5","journal-title":"Prostate Cancer"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BMRJ\/2016\/24047","volume":"13","author":"Ghazy A.","year":"2016","unstructured":"Ghazy A.; El-Sheredy A.; Al-Din K.; Khatab M.; Abdel-Rahman Z.; The effect of IP-10 level and HLA-DP\/DQ polymorphisms on response to nucleoside\/nucleotide analogues treatment among Hepatitis B Egyptian patients. Br Microbiol Res J 2016,13(4),1-11","journal-title":"Br Microbiol Res J"},{"key":"ref=15","first-page":"177","volume":"27","author":"Ghazy A.A.","year":"2020","unstructured":"Ghazy A.A.; Haydara T.; Farooq U.D.; Nadwa E.H.; Ghazy H.A.; Amer I.; Relation between HLA-DP\/DQ polymorphisms, serum IP-10 and response to direct acting antiviral therapy among HCV infected patients. Egypt J Immunol 2020,27(1),177-185","journal-title":"Egypt J Immunol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1016\/j.sjbs.2021.07.037","volume":"28","author":"Taher I.","year":"2021","unstructured":"Taher I.; Almaeen A.; Ghazy A.; Abu-Farha M.; Mohamed Channanath A.; Elsa John S.; Hebbar P.; Arefanian H.; Abubaker J.; Al-Mulla F.; Alphonse Thanaraj T.; Relevance between COVID-19 and host genetics of immune response. Saudi J Biol Sci 2021,28(11),6645-6652","journal-title":"Saudi J Biol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.3748\/wjg.v26.i32.4817","volume":"26","author":"Saribas S.","year":"2020","unstructured":"Saribas S.; Demiryas S.; Yilmaz E.; Uysal O.; Kepil N.; Demirci M.; Caliskan R.; Dinc H.O.; Akkus S.; Gareayaghi N.; Kirmusaoglu S.; Ozbey D.; Tokman H.B.; Koksal S.S.; Tasci I.; Kocazeybek B.; Association between human leukocyte antigen gene polymorphisms and multiple EPIYA-C repeats in gastrointestinal disorders. World J Gastroenterol 2020,26(32),4817-4832","journal-title":"World J Gastroenterol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1423-0127-20-12","volume":"20","author":"Raha O.","year":"2013","unstructured":"Raha O.; Sarkar B.; Lakkakula B.V.K.S.; Pasumarthy V.; Godi S.; Chowdhury S.; Raychaudhuri P.; Vadlamudi R.R.; HLA class II SNP interactions and the association with type 1 diabetes mellitus in Bengali speaking patients of Eastern India. J Biomed Sci 2013,20(1),12","journal-title":"J Biomed Sci"},{"key":"ref=19","unstructured":"IMGT\/HLA Database. Available from:"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.2337\/db12-1398","volume":"62","author":"Nguyen C.","year":"2013","unstructured":"Nguyen C.; Varney M.D.; Harrison L.C.; Morahan G.; Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 2013,62(6),2135-2140","journal-title":"Diabetes"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nbt.2422","volume":"30","author":"Ward L.D.","year":"2012","unstructured":"Ward L.D.; Kellis M.; Interpreting non-coding variation in complex disease genetics Lucas. Nat Biotechnol 2012,30,1095-1106","journal-title":"Nat Biotechnol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","volume":"11","author":"Noble J.A.","year":"2011","unstructured":"Noble J.A.; Valdes A.M.; Genetics of the HLA region in the prediction of type 1 diabetes. Curr Diab Rep 2011,11(6),533-542","journal-title":"Curr Diab Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.2337\/diabetes.53.10.2684","volume":"53","author":"Murao S.","year":"2004","unstructured":"Murao S.; Makino H.; Kaino Y.; Konoue E.; Ohashi J.; Kida K.; Fujii Y.; Shimizu I.; Kawasaki E.; Fujiyama M.; Kondo S.; Tanaka K.; Tarumi Y.; Seto I.; Kato K.; Ohno K.; Kusunoki Y.; Ebisui O.; Takada Y.; Tanabe K.; Takemoto K.; Onuma H.; Nishimiya T.; Osawa H.; Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes 2004,53(10),2684-2690","journal-title":"Diabetes"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2337\/dc18-1785","volume":"42","author":"Sharp S.A.","year":"2019","unstructured":"Sharp S.A.; Rich S.S.; Wood A.R.; Jones S.E.; Beaumont R.N.; Harrison J.W.; Schneider D.A.; Locke J.M.; Tyrrell J.; Weedon M.N.; Hagopian W.A.; Oram R.A.; Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care 2019,42(2),200-207","journal-title":"Diabetes Care"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7705\/biomedica.v38i3.3768","volume":"38","author":"Sarrazola D.C.","year":"2018","unstructured":"Sarrazola D.C.; Rodr&#xED;guez A.M.; Toro M.; V&#xE9;lez A.; Garc&#xED;a-Ram&#xED;rez J.; Lopera M.V.; &#xC1;lvarez C.M.; Gonz&#xE1;lez V.B.; Alfaro J.M.; Pineda-Trujillo N.; Classical HLA alleles tag SNP in families from Antioquia with type 1 diabetes mellitus. Biom&#xE9;dica 2018,38(3),329-337","journal-title":"Biom&#xE9;dica"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1210\/clinem\/dgaa027","volume":"105","author":"Jacobi T.","year":"2020","unstructured":"Jacobi T.; Massier L.; Kl&#xF6;ting N.; Horn K.; Schuch A.; Ahnert P.; Engel C.; L&#xF6;ffler M.; Burkhardt R.; Thiery J.; T&#xF6;njes A.; Stumvoll M.; Bl&#xFC;her M.; Doxiadis I.; Scholz M.; Kovacs P.; HLA class II allele analyses implicate common genetic components in type 1 and non\u2013insulin-treated type 2 diabetes. J Clin Endocrinol Metab 2020,105(3),e245-e254","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/1871530319666191119114031","volume":"20","author":"Khdair S.I.","year":"2020","unstructured":"Khdair S.I.; Jarrar W.; Jarrar Y.B.; Bataineh S.; Al-Khaldi O.; Association of HLA-DRB1 and -DQ alleles and haplotypes with type 1 diabetes in Jordanians. Endocr Metab Immune Disord Drug Targets 2020,20(6),895-902","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00125-019-05032-3","volume":"63","author":"Claessens L.A.","year":"2020","unstructured":"Claessens L.A.; Wesselius J.; van Lummel M.; Laban S.; Mulder F.; Mul D.; Nikolic T.; Aanstoot H.J.; Koeleman B.P.C.; Roep B.O.; Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes. Diabetologia 2020,63(2),351-361","journal-title":"Diabetologia"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666221111153102","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210840\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666221111153102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T12:13:41Z","timestamp":1691324021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210840\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530323666221111153102","relation":{},"ISSN":["1871-5303"],"issn-type":[{"type":"print","value":"1871-5303"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}